Effect of cholecalciferol replacement on vascular calcification and left ventricular mass index in dialysis patients

References

• Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–S119
   PubMed Web of Science ®Google Scholar
• Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med. 2004;351(13):1296–1305
   PubMed Web of Science ®Google Scholar
• Goodman WG, London G, Amann K, et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis. 2004;43(3):572–579
   PubMed Web of Science ®Google Scholar
• Quarles LD. Endocrine functions of bone in mineral metabolism regulation. J Clin Invest. 2008;118(12):3820–3828
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281
   PubMed Web of Science ®Google Scholar
• Autier P, Gandini S. Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167(16):1730–1737
   PubMedGoogle Scholar
• Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503–511
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25OHD and risk of myocardial infarction in men: A prospective study. Arch Intern Med. 2008;168:1174–1180
   PubMed Web of Science ®Google Scholar
• Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340–1349
   PubMed Web of Science ®Google Scholar
• Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older US adults. J Am Geriatr Soc. 2009;57(9):1595–1603
   PubMed Web of Science ®Google Scholar
• Jones G. Why dialysis patients need combination therapy with both cholecalciferol and a calcitriol analogs. Semin Dial. 2010;23(3):239–243
   PubMedGoogle Scholar
• Dusilová-Sulková S, Safránek R, Vávrová J, Horáček J, Pavlíková L, Palička V. Low-dose cholecalciferol supplementation and dual vitamin D therapy in hemodialysis patients. Int Urol Nephrol. 2015;47(1):169–176
   Google Scholar
• Bodyak N, Ayus JC, Achinger S, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci USA. 2007;104(43):16810–16815
   PubMedGoogle Scholar
• Simpson RU, Hershey SH, Nibbelink KA. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol. 2007;103(3-5):521–524
   PubMed Web of Science ®Google Scholar
• Przybylski R, McCune S, Hollis B, Simpson RU. Vitamin D deficiency in the spontaneously hypertensive heart failure (SHHF) prone rat. Nutr Metab Cardiovasc Dis. 2010;20(9):641–646
   PubMed Web of Science ®Google Scholar
• Bae S, Yalamarti B, Ke Q, et al. Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats. Cardiovasc Res. 2011;91(4):632–639
   PubMedGoogle Scholar
• Matias PJ, Jorge C, Ferreira C, et al. Cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol. 2010;5(5):905–911
   PubMed Web of Science ®Google Scholar
• Bucharles S, Barberato SH, Stinghen AE, et al. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism. J Ren Nutr. 2012;22(2):284–291
   PubMedGoogle Scholar
• Mose FH, Vase H, Larsen T, et al. Cardiovascular effects of cholecalciferol treatment in dialysis patients – A randomized controlled trial. BMC Nephrol. 2014;15:50
   PubMed Web of Science ®Google Scholar
• Garcia-Lopes MG, Pillar R, Kamimura MA, et al. Cholecalciferol supplementation in chronic kidney disease: Restoration of vitamin D status and impact on parathyroid hormone. Ann Nutr Metab. 2012;61(1):74–82
   PubMedGoogle Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD–MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD). Kidney Int Suppl. 2009;(113):S1–S130
   Google Scholar
• Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2(5):358–367
   PubMedGoogle Scholar
• Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–458
   PubMed Web of Science ®Google Scholar
• Adragao T, Pires A, Lucas C, et al. A simple vascular calcification score predicts cardiovascular risk in hemodialysis patients. Nephrol Dial Transplant. 2004;19(6):1480–1488
   PubMed Web of Science ®Google Scholar
• Miller JT, O'Rourke RA, Crawford MH. Left atrial enlargement: An early sign of hypertensive heart disease. Am Heart J. 1988;116(4):1048–1051
   PubMed Web of Science ®Google Scholar
• Ristow B, Ali S, Whooley MA, Schiller NB. Usefulness of left atrial volüme index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the Heart and Soul Study). Am J Cardiol. 2008;102(1):70–76
   PubMed Web of Science ®Google Scholar
• Tamez H, Zoccali C, Packham D, et al. Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J. 2012;164(6):902–909.e2
   PubMedGoogle Scholar
• Cardús A, Panizo S, Parisi E, Fernandez E, Valdivielso JM. Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res. 2007;22(6):860–866
   PubMed Web of Science ®Google Scholar
• García-Canton C, Bosch E, Ramírez A, et al. Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant. 2011;26(7):2250–2256
   PubMed Web of Science ®Google Scholar
• Delanaye P, Weekers L, Warling X, et al. Cholecalciferol in hemodialysis patients: A randomized, double-blind, proof-of-concept and safety study. Nephrol Dial Transplant. 2013;28(7):1779–1786
   PubMed Web of Science ®Google Scholar
• Matias PJ, Ferreira C, Jorge C, et al. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in hemodialysis patients. Nephrol Dial Transplant. 2009;24(2):611–618
   PubMedGoogle Scholar
• Jean G, Terrat JC, Vanel T, et al. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in hemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant. 2008;23(11):3670–3676
   PubMed Web of Science ®Google Scholar
• Aguilera A, Sánchez-Tomero JA, Bajo MA, et al. Malnutrition–inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients. Adv Perit Dial. 2003;19:240–245
   PubMedGoogle Scholar
• Demir M, Kucuk A, Sezer MT, Altuntas A, Kaya S. Malnutrition–inflammation score and endothelial dysfunction in hemodialysis patients. J Ren Nutr. 2010;20(6):377–383
   PubMedGoogle Scholar